Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Wyeth Says Chile Approves Prevnar 13 Vaccine

By Pharmaceutical Processing | July 14, 2009

COLLEGEVILLE, Pa. (AP) — Wyeth has reported the first marketing approval for a new version of its vaccine Prevnar, as the drug was cleared by regulators in Chile. Prevnar is the world’s best selling vaccine, with sales of about $2.7 billion in 2008. The original version of the drug blocks seven pneumococcal diseases. The version approved in Chile, which will be marketed under the name Prevenar 13 Valent, is intended to block a total of 13 illnesses. The approval covers children age 6 weeks to 5 years, and Wyeth said it will launch the drug later this year. The company has asked regulators in more than 50 countries to approve Prevnar 13, and the Food and Drug Administration is expected to complete a review by early November. Pneumococcal disease is a group of illnesses caused by Streptococcus pneumoniae. Wyeth said the diseases kills about a million children each year, making them the largest vaccine-preventable killer of children in the world.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE